본문 바로가기
KERD
논문KCI 등재

Long-term tracking of glycosylated hemoglobin levels across the lifespan in type 1 diabetes: from infants to young adults

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류소아과학

초록

Purpose: Glycosylated hemoglobin (HbA1c) is commonly used as a monitoring tool in diabetes. Due to the potential influence of insulin resistance (IR), HbA1c level may fluctuate over a person's lifetime. This study explores the long-term tracking of HbA1c level in individuals diagnosed with type 1 diabetes mellitus (T1DM) from infancy to early adulthood.Methods: The HbA1c levels in 275 individuals (121 males, 43.8%) diagnosed with T1DM were tracked for an average of 9.4 years. The distribution of HbA1c levels was evaluated according to age with subgroups divided by gender, use of continuous glucose monitoring (CGM), and the presence of complications.Results: HbA1c levels were highest at the age of 1 year and then declined until age 4, followed by a significant increase, reaching a maximum at ages 15–16 years. The levels subsequently gradually decreased until early adulthood. This pattern was observed in both sexes, but it was more pronounced in females. Additionally, HbA1c levels were higher in CGM nonusers compared with CGM users; however, regardless of CGM usage, an age-dependent pattern was observed. Furthermore, diabetic complications occurred in 26.8% of individuals, and the age-dependent pattern was observed irrespective of diabetic complications, although HbA1c levels were higher in individuals with diabetic complications.Conclusion: HbA1c levels vary throughout the lifespan, with higher levels during adolescence. This trend is observed regardless of sex and CGM usage, potentially due to physiological IR observed during adolescence. Hence, physiological IR should be considered when interpretating HbA1c levels during adolescence.

Abstract

Purpose: Glycosylated hemoglobin (HbA1c) is commonly used as a monitoring tool in diabetes. Due to the potential influence of insulin resistance (IR), HbA1c level may fluctuate over a person's lifetime. This study explores the long-term tracking of HbA1c level in individuals diagnosed with type 1 diabetes mellitus (T1DM) from infancy to early adulthood.Methods: The HbA1c levels in 275 individuals (121 males, 43.8%) diagnosed with T1DM were tracked for an average of 9.4 years. The distribution of HbA1c levels was evaluated according to age with subgroups divided by gender, use of continuous glucose monitoring (CGM), and the presence of complications.Results: HbA1c levels were highest at the age of 1 year and then declined until age 4, followed by a significant increase, reaching a maximum at ages 15–16 years. The levels subsequently gradually decreased until early adulthood. This pattern was observed in both sexes, but it was more pronounced in females. Additionally, HbA1c levels were higher in CGM nonusers compared with CGM users; however, regardless of CGM usage, an age-dependent pattern was observed. Furthermore, diabetic complications occurred in 26.8% of individuals, and the age-dependent pattern was observed irrespective of diabetic complications, although HbA1c levels were higher in individuals with diabetic complications.Conclusion: HbA1c levels vary throughout the lifespan, with higher levels during adolescence. This trend is observed regardless of sex and CGM usage, potentially due to physiological IR observed during adolescence. Hence, physiological IR should be considered when interpretating HbA1c levels during adolescence.

참고문헌 (40)

  1. Mayer-Davis EJ, "Incidence trends of type 1 and type 2 diabetes among youths, 2002-2012", N Engl J Med, 376, pp.1419~1429 (2017)
  2. Silverstein J, "Care of children and adolescents with type 1 diabetes : a statement of the American Diabetes Association", Diabetes Care, 28, pp.186~212 (2005)
  3. Secrest AM, "Characterizing sudden death and dead-in-bed syndrome in Type 1 diabetes : analysis from two childhood-onset type 1 diabetes registries", Diabet Med, 28, pp.293~300 (2011)
  4. Stettler C, "Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus : meta-analysis of randomized trials", Am Heart J, 152, pp.27~38 (2006)
  5. American Diabetes Association, "(2)Classification and diagnosis of diabetes", Diabetes Care, 38(Suppl), pp.S8~S16 (2015)
  6. Brown A, "Intensive glycemic control and cardiovascular disease : an update", Nat Rev Cardiol, 7, pp.369~375 (2010)
  7. American Diabetes Association Professional Practice Committee, "6. Glycemic targets : standards of medical care in diabetes-2022", Diabetes Care, 45(Suppl 1), pp.S83~S96 (2022)
  8. Gerstl EM, "Metabolic control as reflected by HbA1c in children, adolescents and young adults with type-1 diabetes mellitus : combined longitudinal analysis including 27, 035patients from 207 centers in Germany and Austria during the last decade", Eur J Pediatr, 167, pp.447~453 (2008)
  9. Guercio G, "Relationship between the growth hormone", insulinlike growth factor-I axis, insulin sensitivity, and adrenal androgens in normal prepubertal and pubertal girls, 2003, pp.88, 1389~1393
  10. Cook JS, "Effects of maturational stage on insulin sensitivity during puberty", J Clin Endocrinol Metab, 77, pp.725~730 (1993)
  11. Roemmich JN, "Pubertal alterations in growth and body composition. VI. Pubertal insulin resistance : relation to adiposity, body fat distribution and hormone release", Int J Obes Relat Metab Disord, 26, pp.701~709 (2002)
  12. Amiel SA, "Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes", N Engl J Med, 315, pp.215~219 (1986)
  13. Ball GD, "Longitudinal changes in insulin sensitivity, insulin secretion, and beta-cell function during puberty", J Pediatr, 148, pp.16~22 (2006)
  14. Jeffery AN, "Age before stage : insulin resistance rises before the onset of puberty : a 9-year longitudinal study(EarlyBird 26)", Diabetes Care, 35, pp.536~541 (2012)
  15. Lee JM, "Prevalence and determinants of insulin resistance among U. S. adolescents : a population-based study", Diabetes Care, 29, pp.2427~2432 (2006)
  16. Peplies J, "Percentiles of fasting serum insulin, glucose, HbA1c and HOMA-IR in pre-pubertal normal weight European children from the IDEFICS cohort", Int J Obes (Lond), 38(Suppl 2), pp.S39~S47 (2014)
  17. Greenbaum CJ, "Insulin resistance in type 1 diabetes", Diabetes Metab Res Rev, 18, pp.192~200 (2002)
  18. Rahmati M, "The global impact of COVID-19 pandemic on the incidence of pediatric new-onset type 1 diabetes and ketoacidosis : a systematic review and meta-analysis", J Med Virol, 94, pp.5112~5127 (2022)
  19. Shashaj B, "Reference ranges of HOMA-IR in normal-weight and obese young Caucasians", Acta Diabetol, 53, pp.251~260 (2016)
  20. Almeida CA, "Determination of glycemia and insulinemia and the homeostasis model assessment(HOMA)in schoolchildren and adolescents with normal body mass index", J Pediatr(Rio J), 84, pp.136~140 (2008)
  21. Hovestadt I, "HbA1c percentiles and the association between BMI, age, gender, puberty, and HbA1c levels in healthy German children and adolescents", Pediatr Diabetes, 23, pp.194~202 (2022)
  22. Gordon CM, "Changing needs of the patient with diabetes mellitus during the teenage years", Curr Opin Pediatr, 8, pp.319~327 (1996)
  23. Pinhas-Hamiel O, "Trajectories of HbA1c levels in children and youth with type 1 diabetes", PLoS One, 9, pp.e109109~ (2014)
  24. Hoffman RP, "Pubertal adolescent male-female differences in insulin sensitivity and glucose effectiveness determined by the one compartment minimal model", Pediatr Res, 48, pp.384~388 (2000)
  25. Moran A, "Insulin resistance during puberty : results from clamp studies in 357 children", Diabetes, 48, pp.2039~2044 (1999)
  26. Kim S, "Trends in HOMA-IR values among South Korean adolescents from 2007-2010 to 2019-2020 : a sex-, age-, and weight status-specific analysis", Int J Obes(Lond), 47, pp.865~872 (2023)
  27. Travers SH, "Gender and Tanner stage differences in body composition and insulin sensitivity in early pubertal children", J Clin Endocrinol Metab, 80, pp.172~178 (1995)
  28. Foster NC, "State of type 1 diabetes management and outcomes from the T1D exchange in 2016-2018", Diabetes Technol Ther, 21, pp.66~72 (2019)
  29. Teo E, "Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus : a systematic review of randomised controlled trials and meta-analysis", Diabetologia, 65, pp.604~619 (2022)
  30. Lin R, "Continuous glucose monitoring : a review of the evidence in type 1 and 2 diabetes mellitus", Diabet Med, 38, pp.e14528~ (2021)
  31. Hermanns N, "Impact of CGM on the management of hypoglycemia problems : overview and secondary analysis of the HypoDE study", J Diabetes Sci Technol, 13, pp.636~644 (2019)
  32. Lockhart MJ, "Should continuous glucose monitoring systems be offered to all patients with type 1diabetes mellitus?", Ir J Med Sci, 191, pp.957~960 (2022)
  33. Hovind P, "Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes : inception cohort study", BMJ, 328, pp.1105~ (2004)
  34. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial, "Diabetes Control and Complications Trial Research Group", J Pediatr, 125, pp.177~188 (1994)
  35. Morales A, "A better future for children with type 1 diabetes : review of the conclusions from the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study", J Ark Med Soc, 106, pp.90~93 (2009)
  36. Burger W, "Prevalence and development of retinopathy in children and adolescents with type 1(insulin-dependent)diabetes mellitus. A longitudinal study", Diabetologia, 29, pp.17~22 (1986)
  37. Cho YH, "Puberty as an accelerator for diabetes complications", Pediatr Diabetes, 15, pp.18~26 (2014)
  38. Danne T, "Factors modifying the effect of hyperglycemia on the development of retinopathy in adolescents with diabetes. Results of the Berlin Retinopathy Study", Horm Res, 50(Suppl 1), pp.28~32 (1998)
  39. Nordwall M, "Impact of age of onset, puberty, and glycemic control followed from diagnosis on incidence of retinopathy in type 1 diabetes : the VISS study", Diabetes Care, 42, pp.609~616 (2019)
  40. Sosenko JM, "Muscle capillary basement-membrane thickness and longterm glycemia in type I diabetes mellitus", N Engl J Med, 311, pp.694~698 (1984)

관련 논문AI추천

Features of partial remission in children with type 1 diabetes using the insulin dose-adjusted A1c definition and risk factors associated with nonremissionBut Wai Man Betty, Wong Man Yee Shirley, Wong Tsz Wai Catherine대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2021 · 제26권 제2호The role of continuous glucose monitoring in improving glycemic control in adolescents with type 1 diabetesKang Eungu, Kim EunJeong, Lee Kee-Hyoung, Nam Hyo-Kyoung, Park Ji Won, Park Kyu Hyun, Rhie Young-Jun, Seo Minkyu, Shin Do young대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2025 · 제30권 제5호Usefulness of glycated albumin level as a glycemic index complementing glycosylated hemoglobin in diabetic children and adolescentsAhn Moon Bae, Choi Young Ju, Cho Kyoung Soon, Cho Won Kyoung, Jung Min Ho, Kim Shin Hee, Lee Na Yeong, Suh Byung-Kyu대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2023 · 제28권 제4호Serum glycated albumin as a new glycemic marker in pediatric diabetes권영세, 김순기, 김형진, 이지우, 이지은, 전용훈, 최종원대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2013 · 제18권 제4호Serum lipid profiles and glycemic control in adolescents and young adults with type 1 diabetes mellitus김신희, 서병규, 전연진, 정민호, 정인아, 조경순, 조원경대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2014 · 제19권 제4호Effect of adherence to carbohydrate counting on metabolic control in children and adolescents with type 1 diabetes mellitusGül Kızıltan, Onur Akın, Sinem Bayram대한소아내분비학회 · Annals of Pediatric Endocrinology & Metabolism2020 · 제25권 제3호

이 간행물의 다른 논문 (8건)